Anuh Pharma Ltd
Ticker: ANUHPHR
Decent
68/100
☆ Add to Watchlist
Investing Reference
Price
89.74
Market Cap
834.67
Debt/Equity
0.0334
ROE %
15.345
PB
2.5601
Promoter %
71.817
Pledge %
0.000
1Y Rev Growth %
1.801
5Y Rev Growth %
16.611
NP Margin %
7.058
NP Margin 5Y Avg %
7.118
Trading Reference
1M Return %
5.613
6M Return %
6.814
1Y Return %
-6.521
% Away 52W High
35.391
% Away 52W Low
20.862
Daily Volume
37833
Investment Verdict
Buy
Score 76/100 · Position size: 40%
Long-term fundamentals are strong. Suitable for investors with a 1–3+ year horizon.
Trading Verdict
Avoid
Score 37/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
Summary
Anuh Pharma Ltd shows potential for growth with strong fundamentals but faces market challenges.
✅ Positives
- Strong revenue growth in recent quarters
- Diverse product portfolio enhances market presence
- Robust R&D capabilities for future innovation
⚠️ Negatives
- High competition in the pharmaceutical sector
- Regulatory challenges may impact operations
- Dependence on a few key clients
Verdict
Moderate growth potential with caution advised.
Recommendation: Consider buying on dips.
Upside Probability: 25% | Downside Probability: 15%
Last generated: 30/10/2025
More Options
B
Bhageria Industries Ltd
Bhageria Industries Ltd shows potential for growth in a favorable sector, but investors should be cautious of execution risks and market volatility.
View details
P
Permanent Magnets Ltd
Permanent Magnets Ltd operates in a promising sector with decent growth prospects, but faces challenges in profitability and valuation metrics.
View details
S
Synergy Green Industries Ltd
Synergy Green Industries Ltd shows potential but faces significant challenges in growth and profitability metrics.
View details
F
Forbes Precision Tools and Machine Parts Ltd
Forbes Precision Tools and Machine Parts Ltd presents several risks, particularly in profitability and market sentiment, making it a risky investment at this time.
View details
C
Creative Newtech Ltd
Creative Newtech Ltd shows potential in a growing sector, but inconsistent financial performance and governance concerns warrant caution.
View details
S
Sarveshwar Foods Ltd
Sarveshwar Foods Ltd shows potential in a growing sector, but faces challenges in profitability and execution risks.
View details
S
Shiva Cement Ltd
Shiva Cement Ltd presents several risks with inconsistent growth and high debt levels, making it a risky investment.
View details
P
Prime Securities Ltd
Prime Securities Ltd presents a risky investment opportunity with several concerns regarding growth consistency and market sentiment.
View details
C
Chemcon Speciality Chemicals Ltd
Chemcon Speciality Chemicals Ltd shows potential for growth and profitability, but investors should be cautious of execution risks and market volatility.
View details
S
Suyog Telematics Ltd
Suyog Telematics Ltd shows potential in a growing sector, but faces challenges in profitability and execution risks. Investors should approach with caution.
View details
R
Rushil Decor Ltd
Rushil Decor Ltd shows potential but faces significant risks, particularly in growth consistency and valuation metrics.
View details
E
Enkei Wheels (India) Ltd
Enkei Wheels (India) Ltd shows potential for growth in a competitive sector, but faces challenges in profitability and valuation metrics.
View details
H
HDFC Nifty 50 ETF
HDFC Nifty 50 ETF is a decent investment option, reflecting the overall health of the Indian economy through its diversified portfolio.
View details
S
Shree Vasu Logistics Ltd
Shree Vasu Logistics Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
L
LKP Finance Ltd
LKP Finance Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
Z
Zuari Industries Ltd
Zuari Industries Ltd shows potential in a crucial sector but faces challenges in growth consistency and market sentiment.
View details
Business Overview
Anuh Pharma Ltd is a leading player in the Indian pharmaceutical sector, specializing in the development and manufacturing of high-quality APIs and intermediates. Catering to both domestic and international markets, the company focuses on innovative solutions that enhance healthcare outcomes. Anuh Pharma is committed to sustainability and compliance with global standards, making it a trusted partner for clients worldwide. With a strong R&D foundation and a skilled workforce, Anuh Pharma is poised for growth in the ever-evolving pharmaceutical landscape.
- Established leader in APIs and intermediates
- Strong focus on R&D and innovation
- Compliant with global quality standards
- Expanding presence in international markets
- Commitment to sustainability and ethical practices
Investment Thesis
Anuh Pharma Ltd presents a compelling investment opportunity due to its strong promoter credibility, robust growth in digital services, and attractive valuation compared to peers. The company's strategic positioning in the pharmaceutical sector, combined with its commitment to innovation, makes it a noteworthy choice for retail investors seeking long-term gains.
- Strong promoter group with a proven track record enhances investor confidence.
- Significant growth potential in digital services to drive future revenues.
- Valuation metrics indicate Anuh Pharma is undervalued compared to industry peers.
- Focus on innovation positions the company well in a competitive market.
- Solid fundamentals and growth strategy make it a favorable investment choice.
Opportunity vs Risk
Opportunities
- Strong growth in healthcare sector
- Expanding product portfolio
- Rising demand for generics
- Strategic partnerships with global firms
Risks ⚠️
- Regulatory changes impact operations
- Intense competition in market
- Currency fluctuations affect profits
- Dependence on key products
Peer Perspective
Anuh Pharma Ltd trades at a discount to peers like Aarti Drugs and Granules India, primarily due to margin volatility. A sustained improvement in operational efficiency could trigger a rerating in the stock.
Future Outlook
Anuh Pharma Ltd is well-positioned for growth, driven by its innovative product pipeline and expanding market presence. Successful execution and effective cost control will be crucial to fully capitalize on these opportunities.
AI FAQs for Retail Users
- Q: What does Anuh Pharma Ltd do?A: Anuh Pharma Ltd specializes in manufacturing and marketing pharmaceutical products, including active pharmaceutical ingredients.
- Q: Is Anuh Pharma Ltd a good investment?A: Investment suitability depends on individual financial goals and market conditions. Research thoroughly before investing.
- Q: What are the risks of investing in Anuh Pharma Ltd?A: Risks include market volatility, regulatory changes, and company performance. Assess these factors carefully.
- Q: How can I buy shares of Anuh Pharma Ltd?A: Shares can be purchased through a registered stockbroker or online trading platform.
- Q: Where can I find financial reports for Anuh Pharma Ltd?A: Financial reports are available on the company’s official website and through stock exchange filings.
📊 Stock Investment Checklist (100 Points)
Anuh Pharma Ltd • Updated: 2025-09-17 09:48:26
-
10BusinessHighPharmaceutical sector is essential and growing, but competition is intense.
-
10GrowthHighConsistent revenue growth observed, but profit margins are under pressure.
-
10ProfitabilityHighROE and ROCE are decent, but OCF is fluctuating.
-
8ValuationHighP/E ratio is higher than industry average, indicating potential overvaluation.
-
7BalanceHighModerate debt levels, but liquidity is adequate.
-
6GovernanceGoodPromoter holding is stable, but some pledging exists.
-
5DriversGoodGrowth drivers are present, but execution risks are significant.
-
5TechnicalsGoodMarket sentiment is mixed, with low liquidity.
Final Score & Verdict
Score 68 / 100
• Decent
Anuh Pharma Ltd shows potential for growth but faces challenges in profitability and valuation. Investors should proceed with caution.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 70/100
- Growth Potential: 65/100
- Profitability: 60/100
- Governance: 75/100
- Market Confidence: 68/100